Deep Track Capital, LP - 09 Mar 2026 SCHEDULE 13G Report for Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value (ACRS)

Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Security
Aclaris Therapeutics, Inc. Common Stock, $0.00001 par value
Symbol
ACRS
Shares outstanding
133,500,000 shares
Disclosed Ownership
9,345,000 shares
Ownership
7%
Form type
SCHEDULE 13G
Filing time
17 Mar 2026, 16:16:51 UTC
Date of event
09 Mar 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 7% 9,345,000 0 9,345,000 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 7% 9,345,000 0 9,345,000 /s/ David Kroin David Kroin, Director
David Kroin 7% 9,345,000 0 9,345,000 /s/ David Kroin David Kroin